Description
The webinar will provide an overview of current professional practice guidelines and scientific publications on long-acting injectable antipsychotics use in treatment of schizophrenia. Many patients diagnosed with schizophrenia who are eligible for treatment LAI antipsychotics are limited in access to this treatment modality because of clinicians limited on advantages of LAIs over oral antipsychotics. Learners need to understand how utilization of LAIs in evidence-based prescribing can improve patient outcomes and decrease health care cost in treatment of patients with schizophrenia. This activity provides information on the professional guidelines on use of LAIs in treatment of patients with schizophrenia and specific advantages of selecting evidence-based treatment to improve patient outcomes.
Format
Recorded webinar, non-interactive, self-paced distance learning activity with post-test.
This presentation was recorded on March 2, 2022.
Learning Objectives
Review the American Psychiatric Association statements on utilizing LAIs in treatment of patients with schizophrenia.
Examine key findings in the peer-reviewed publications on oral vs. long-acting injectable antipsychotic use in patients with schizophrenia.
Contrast research findings on the first- and second-generation long-acting injectable antipsychotics
Outline
- Introduction & Presentation Details
- Foundational Concepts & Definitions
- Clinical Guidelines: APA Recommendations
- Literature Review: Oral (OAP) vs. Long-Acting Injectable (LAI) Antipsychotics
- Summary: FGA-LAI vs. SGA-LAI
Target Audience
Psychiatrist, Physician (Non-Psychiatric), Physician Assistant, Nurse, Nurse Practitioner, Pharmacist
Instruction Level
Intermediate
Estimated Time to Complete
Estimated Duration: 1.0 hour
Program Start Date: July 30, 2025
Program End Date: July 30, 2028
Ongoing Interdisciplinary Discussion Board
After completing the course, engage with colleagues in the mental health field through the Webinar Roundtable Topics discussion board. This is an easy way to network and share ideas with other clinicians who participate in this webinar. Access through the discussion tab.
How to Earn Credit
After completing the evaluation, participants will have the opportunity to claim their hours of participation and download the appropriate certificate. Physicians may obtain an official CME certificate, other healthcare professionals may receive a CE certificate (as applicable), and all other attendees may generate a certificate of participation. Each certificate will reflect the event date and total hours earned.
Continuing Education Credit
In support of improving patient care, American Psychiatric Association (APA) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The APA designates this live event for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses/Nurse Practitioners
The American Psychiatric Association (APA) designates this activity for 1.00 Nursing contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME's Standards for Integrity and Independence in Accredited Medical Education. Any individuals in a position to control the content of a CME activity - including faculty, planners, reviewers, or others - are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Faculty
- Leon Ravin, MD has been the statewide psychiatric medical director in Nevada since August 2015, and previously served as an associate medical director. Since 2006, he has worked in clinical and administrative roles at Southern Nevada Adult Mental Health Services, including taking an active role in testifying on mental health laws and community standards of care before the Nevada Legislature. Dr. Ravin has been the director of graduate and postgraduate medical education for the state Division of Public and Behavioral Health since 2012 while also teaching as a clinical professor for the University of Nevada School of Medicine. Dr. Ravin serves as an expert for SMI Adviser’s Long-acting Injectable Center of Excellence. Dr. Ravin is a member of the Janssen Neuroscience Mood Speaker Bureau and has developed non-promotional content for PsychU on Psychiatric Advance Directives
Program Planners
- Teri Brister, PhD, LPC, National Alliance on Mental Illness. Reports no financial relationships with commercial interests.
- John Torous, MD, Beth Israel Deaconess Medical Center. Reports no financial relationships with commercial interests.
- Donna Rolin, PhD, APRN, University of Texas at Austin. Reports no financial relationships with commercial interests.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
Internet Explorer 11+
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
Internet Connection: 1 Mbps or higher
Minimum Requirements:
Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact educme@psych.org for questions about this activity |
Contact support@smicaladviser.org for technical assistance